Author

Mandour Omer Mandour

Observed name: Mandour O Mandour

Institutions: University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Wellcome/MRC Institute of Metabolic Science, NIHR Cambridge Biomedical Research Centre

Observed institutions: St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Wellcome/MRC Institute of Metabolic Science, NIHR Cambridge Biomedical Research Centre

ORCID: 0000-0002-1234-4260

Observed ORCID: 0000-0002-1234-4260

OpenAlex ID: A5083368810

Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidation

2025 · Qiyu Zeng, Satish Patel, et al. · Journal of Hepatology · 11

Thrombotic complications following bariatric surgery: how medical tourism poses challenges to comprehensive care in obesity medicine

2024 · Mandour Omer Mandour, Robert Bakewell, et al. · Clinical Journal of Gastroenterology · 4

Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy

2026 · Mandour O Mandour, Anna Stears, et al. · The Journal of Clinical Endocrinology & Metabolism · 3

Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?

2022 · Mandour Omer Mandour, Mohammed El-Hassan, et al. · World Journal of Hepatology · 2

P10 Reduced utility of FIB4 as a non-invasive test for advanced liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease and severe obesity

2026 · Igor Yakunin, Saptarshi Maitra, et al.

P167 Glucagon-like peptide-1 receptor analogues for obese patients needing liver transplantation

2026 · Gwilym Webb, Madeline Whitbread, et al.

The Obesity Paradox in Cardiothoracic Surgery

2022 · Mandour Omer Mandour · American Journal of Biomedical Science & Research

Works count: 7

Citation count: 20

H-index: 3

I10-index: 1